• Work with us
  • External Contractors
Fondazione Toscana Life Sciences
  • IT
  • EN
Toscana Life Sciences
  • THE FOUNDATION
    • Organization
    • History
    • Membership
    • The Legislative Decree No. 231/2001
  • Activity
  • Cluster
  • ITS VITA
  • BIOINCUBATOR
    • Join the Bioincubator
    • Incubated companies
    • Research groups
    • Affiliated companies
  • Services
    • Business development services
    • Research services
    • Incubation services
    • Protection of intellectual property
  • Projects
    • ERC Advanced Grant OMVac
    • Monoclonal Antibody Discovery (MAD) LAB
    • ERC Advanced Grant VACCIBIOME
    • My First AIRC grant @Tumour Immunology Unit
    • Regions4PerMed
    • COSME-AI4DIAG
    • IDF SHARID
    • BORNTOGEtTHERe
    • SINO-EU‐PERMED
    • Orphan diseases
  • Disseminating
    • TLS Open Doors
    • Scientists for a day
    • Science + Economy = Business
    • Researcher’s Night
    • European Biotech Week
  • TLS4Covid19
  • Stories
Enter any keyword and press enter

Anthea Di Rita

  • Projects
    • ERC Advanced Grant OMVac
    • Monoclonal Antibody Discovery (MAD) LAB
    • ERC Advanced Grant VACCIBIOME
    • My First AIRC grant @Tumour Immunology Unit
    • Regions4PerMed
    • COSME-AI4DIAG
    • IDF SHARID
    • BORNTOGEtTHERe
    • SINO-EU‐PERMED
< Back to project

Anthea Di Rita

Anthea Di Rita trained as cellular and molecular biologist at the laboratory of Prof. Francesco Cecconi at the University of Rome Tor Vergata (Italy), where she obtained her Master degree in Cellular and Molecular Biology in 2014 and then a PhD in Cellular and Molecular Biology in 2017. Her PhD thesis dealt with the role of AMBRA1 protein in a selective form of autophagy for mitochondria clearance, known as mitophagy, in physiologic and pathologic conditions. She worked as post-doctoral fellow in the laboratory of Dr. Flavie Strappazzon at the IRCCS Santa Lucia Foundation (Rome, Italy), where she obtained the certificate FESALA licenses for performing and directing experiments involving animals. During her first Post-Doc, she consolidated her expertise in mitochondrial biology expanding her competences in mitochondria-related micro-RNA (miRNA) regulation and autoimmunity diseases, such as Multiple Sclerosis. She has recently joined the group led by Dr. Anna Kabanova at Fondazione Toscana Life Sciences (TLS) in Siena. She works on the AIRC granted project focused on the inhibitory gene expression programs in the Chronic Lymphocytic Leukaemia (CLL) and their therapeutic potential.


Contacts:

Cristina Tinti
c.tinti@toscanalifesciences.org


Principal Investigator of the Tumour Immunology Unit:

Anna Kabanova
a.kabanova@toscanalifesciences.org

Research Group:
Anthea Di Rita
Laura Pezzella
Federica Nardi

Fondazione Toscana Life Sciences
Via Fiorentina, 1
53100 Siena – ITALIA

  • tel +39 0577 231211
  • fax +39 0577 43444
  • info@toscanalifesciences.org; info@pec.fondazionetls.org

Twitter Feeds

🗣La Dottoressa Claudia Sala, ricercatrice del Mad Lab di Tls, al microfono 🎤de L'inviato Speciale di Radio1 Rai fa…

@FondazioneTLS 10 Hours Ago

RT @Radio1Rai: Pronto per la sperimentazione clinica l'anticorpo monoclonale italiano "J-08", sviluppato a #Siena grazie al lavoro della @F…

@FondazioneTLS 11 Hours Ago

In occasione della Giornata delle Malattie Rare 2021 la @regionetoscana organizza un evento online sabato 27 febbr…

@FondazioneTLS About a Day Ago

Contatti

    Concedo il consenso al trattamento dei dati personali secondo la nostra Privacy Policy per poter essere contattato da Fondazione Toscana Life Sciences.

©2015-2019 - Fondazione Toscana Life Sciences - P.I. 01194710529 - Codice SDI: SUBM70N - Privacy - Cookie Policy